David Leung
29Patents
11h-index
31Co-inventors
75Inventor score
Filing activity: Nov 1, 1982 → Jan 31, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5223408A | Method for making variant secreted proteins with altered properties | Chemistry; Metallurgy | 203 | Expired |
| US5332671A | Production of vascular endothelial cell growth factor and DNA encoding same | Human Necessities | 174 | Expired |
| US4775622A | Expression, processing and secretion of heterologous protein by yeast | Emerging Cross-Sectional Technologies | 156 | Expired |
| US5736135A | Method for making variant secreted proteins with altered properties | Chemistry; Metallurgy | 75 | Expired |
| US5807861A | Amine substituted xanthinyl compounds | Chemistry; Metallurgy | 73 | Expired |
| US5057417A | Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein | Human Necessities | 73 | Expired |
| US7052891B2 | Human lysophoshatidic acid acyltransferase gamma-1 polypeptide | Chemistry; Metallurgy | 52 | Expired |
| US8129348B2 | Conjugates of biologically active proteins having a modified in vivo half-life | Emerging Cross-Sectional Technologies | 49 | Active |
| US4857637A | Methods and compositions for immunologically modulating growth hormone receptor activity | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5688763A | Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein | Human Necessities | 22 | Expired |
| US6171824A | Hybrid cytokines | Chemistry; Metallurgy | 14 | Expired |
| US5756511A | Method for treating symptoms of a neurodegenerative condition | Human Necessities | 8 | Expired |
| US7135314B1 | Human phosphatidic acid phosphatase | Chemistry; Metallurgy | 6 | Expired |
| US5859222A | Human phosphatidylcholine phospholipase D | Chemistry; Metallurgy | 5 | Expired |
| US5985926A | Method for inhibiting intracellular viral replication | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6503700B1 | Mammalian CDP-diacylglycerol synthase | Chemistry; Metallurgy | 4 | Expired |
| US6300487A | Mammalian lysophosphatidic acid acyltransferase | Chemistry; Metallurgy | 2 | Expired |
| US5952480A | Mammalian CDP-diacylglycerol synthase | Chemistry; Metallurgy | 1 | Expired |
| US7064125B2 | LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US7608620B2 | LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US6274363A | Phosphatidylcholine phospholipase D | Chemistry; Metallurgy | 0 | Expired |
| US6670143B2 | Method of screening compounds that inhibit lysophosphatidic acid acyltransferase | Chemistry; Metallurgy | 0 | Expired |
| US6060263A | Mammalian lysophosphatidic acid acyltransferase | Chemistry; Metallurgy | 0 | Expired |
| US6200769A | Mammalian CDP-diacylglycerol synthase | Chemistry; Metallurgy | 0 | Expired |
| US7045327B2 | Human lysophosphatidic acid acyltransferase gamma-2 polypeptide | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.